- Filed
- Aug 17, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2020 · Aug 12, 2020 | 34.48M sh |
| Stock Repurchased | Q2 2020 · Jun 30, 2020 | $0 |
| Stock Repurchased | Q2 2020 · Jun 30, 2019 | $13.73M |
| Capex | Q2 2020 · Jun 30, 2020 | $68K |
| Capex | Q2 2020 · Jun 30, 2019 | $1.91M |
| Operating Cash Flow | Q2 2020 · Jun 30, 2020 | −$43.44M |
| Operating Cash Flow | Q2 2020 · Jun 30, 2019 | −$96.45M |
| Long Term Debt | Q2 2020 · Jun 30, 2020 | $285.14M |
| Long Term Debt | Q2 2020 · Dec 31, 2019 | $277.03M |
| Short Term Debt | Q2 2020 · Jun 30, 2020 | $0 |
| Short Term Debt | Q2 2020 · Dec 31, 2019 | $0 |
| Cash And Equivalents | Q2 2020 · Jun 30, 2020 | $98.52M |
| Cash And Equivalents | Q2 2020 · Dec 31, 2019 | $113.01M |
| Stockholders Equity | Q2 2020 · Jun 30, 2020 | $249.32M |
| Stockholders Equity | Q2 2020 · Mar 31, 2020 | $259.22M |
| Stockholders Equity | Q2 2020 · Dec 31, 2019 | $279.82M |
| Stockholders Equity restated | Q2 2020 · Jun 30, 2019 | $493.75M |
| Stockholders Equity restated | Q2 2020 · Mar 31, 2019 | $609.31M |
| Stockholders Equity restated | Q2 2020 · Dec 31, 2018 | $741.56M |
| Current Liabilities | Q2 2020 · Jun 30, 2020 | $161M |
| Current Liabilities | Q2 2020 · Dec 31, 2019 | $214.5M |
| Total Liabilities | Q2 2020 · Jun 30, 2020 | $466.23M |
| Total Liabilities | Q2 2020 · Dec 31, 2019 | $511.41M |
| Current Assets | Q2 2020 · Jun 30, 2020 | $263.56M |
| Current Assets | Q2 2020 · Dec 31, 2019 | $316.57M |
| Total Assets | Q2 2020 · Jun 30, 2020 | $715.55M |
| Total Assets | Q2 2020 · Dec 31, 2019 | $791.23M |
| Sga Expense | Q2 2020 · Jun 30, 2020 | $39.57M |
| Sga Expense | Q2 2020 · Jun 30, 2020 | $92.27M |
| Sga Expense | Q2 2020 · Jun 30, 2019 | $77.32M |
| Sga Expense | Q2 2020 · Jun 30, 2019 | $152.01M |
| Net Income | Q2 2020 · Jun 30, 2020 | −$13.24M |
| Net Income | Q2 2020 · Jun 30, 2020 | −$35.95M |
| Net Income restated | Q2 2020 · Jun 30, 2019 | −$121.17M |
| Net Income restated | Q2 2020 · Jun 30, 2019 | −$243.57M |
| Operating Income | Q2 2020 · Jun 30, 2020 | −$7.01M |
| Operating Income | Q2 2020 · Jun 30, 2020 | −$24.8M |
| Operating Income restated | Q2 2020 · Jun 30, 2019 | −$116.19M |
| Operating Income restated | Q2 2020 · Jun 30, 2019 | −$234.2M |
| Cost Of Revenue | Q2 2020 · Jun 30, 2020 | $18.18M |
| Cost Of Revenue | Q2 2020 · Jun 30, 2020 | $42.54M |
| Cost Of Revenue | Q2 2020 · Jun 30, 2019 | $24.29M |
| Cost Of Revenue | Q2 2020 · Jun 30, 2019 | $42.77M |
| Revenue | Q2 2020 · Jun 30, 2020 | $52.76M |
| Revenue | Q2 2020 · Jun 30, 2020 | $123.2M |
| Revenue restated | Q2 2020 · Jun 30, 2019 | $77.77M |
| Revenue restated | Q2 2020 · Jun 30, 2019 | $153.26M |